Starlight Cardiovascular, Inc.
San Diego, CA Doing business as Starlight Cardiovascular Inc.
- UEI
- W3TSK3T9QHJ7
- CAGE
- 8NXF0
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 9710 Scranton Rd #100, San Diego, CA 92121, USA
- Website
- starlightcardio.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Commercialization readiness of a pulmonary flow restrictor for hypoplastic left heart syndrome - abstract starlight… | National Heart Lung and Blood Institute | $499,952 | |
| Commercialization readiness for ductus arteriosus stent to improve congenital heart defect mortality - abstract the… | National Heart Lung and Blood Institute | $500,000 | |
| Development of a pulmonary flow restrictor for hypoplastic left heart syndrome - abstract starlight cardiovascular is… | National Heart Lung and Blood Institute | $8,598,457 | |
| Development of a pulmonary flow restrictor for hypoplastic left heart syndrome - abstract starlight cardiovascular is… | National Heart Lung and Blood Institute | $896,000 | |
| Ductus arteriosus stent to improve congenital heart defect mortality - abstract the technical challenges faced by… | National Heart Lung and Blood Institute | $9,414,284 |
About Starlight Cardiovascular, Inc.
Starlight Cardiovascular, Inc. is a for-profit corporate entity registered in SAM.gov, headquartered in San Diego, California, that specializes in developing innovative medical devices for pediatric cardiovascular interventions. The company focuses on creating specialized medical technologies designed to address complex congenital heart defects, with a particular emphasis on developing stents and flow restrictors specifically tailored for newborns and infants with challenging cardiovascular conditions.
Through federal grant awards from the National Heart, Lung, and Blood Institute (NHLBI), Starlight Cardiovascular has received multiple Project Grants under the Cardiovascular Diseases Research program to develop groundbreaking pediatric cardiovascular technologies. The company has been developing three primary medical devices: a ductus arteriosus stent system to maintain critical blood vessel patency in newborns, a pulmonary flow restrictor for hypoplastic left heart syndrome, and a percutaneous flow restrictor to replace surgical banding in congenital heart defects. These grants, ranging from $500,000 to over $1.4 million, have supported the company's research and development efforts through Phase I and Phase II SBIR (Small Business Innovation Research) programs. Starlight has also engaged in sub-grant collaborations with entities like Children's Research Institute and the University of California, San Francisco, to advance its pediatric device innovation initiatives. The company's ultimate goal is to obtain FDA approval and commercialize these innovative medical devices to improve treatment outcomes for infants with complex cardiovascular conditions.
Quick answers
What is Starlight Cardiovascular, Inc.'s UEI?
Starlight Cardiovascular, Inc.'s Unique Entity ID (UEI) in SAM.gov is W3TSK3T9QHJ7.
What is Starlight Cardiovascular, Inc.'s CAGE code?
Starlight Cardiovascular, Inc.'s CAGE code is 8NXF0.
What is Starlight Cardiovascular, Inc.'s primary NAICS code?
Starlight Cardiovascular, Inc.'s primary NAICS code is 339112 (Surgical and Medical Instrument Manufacturing).
Where is Starlight Cardiovascular, Inc. located?
Starlight Cardiovascular, Inc.'s physical address in SAM.gov is 9710 Scranton Rd #100, San Diego, CA 92121, USA.
Is Starlight Cardiovascular, Inc. registered in SAM.gov?
Yes. Starlight Cardiovascular, Inc.'s SAM.gov registration is active through July 24, 2027.
What is Starlight Cardiovascular, Inc.'s most recent federal award?
Starlight Cardiovascular, Inc.'s most recent federal grant award is Commercialization readiness of a pulmonary flow restrictor for hypoplastic left heart syndrome - abstract starlight… (SB1HL184388), from National Heart Lung and Blood Institute, on August 10, 2026.
On GovTribe
See Starlight Cardiovascular, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors